Online citations, reference lists, and bibliographies.

Intestinal Microbiota Was Assessed In Cirrhotic Patients With Hepatitis B Virus Infection

Haifeng Lu, Zhongwen Wu, W. Xu, Jiezuan Yang, Y. Chen, L. Li
Published 2010 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
To unravel the profile of intestinal microecological parameters in Chinese patients with asymptomatic carriage of hepatitis B virus (HBV), chronic hepatitis B, decompensated HBV cirrhosis, and health controls and to establish their correlation with liver disease progression, we performed quantitative PCR and immunological techniques to investigate fecal parameters, including population of fecal predominant bacteria and the abundance of some virulence genes derived from Escherichia coli, Bacteroides fragilis, Clostridium difficile, and Clostridium perfringens in fecal crude DNA and some immunological parameters in extracts of all fecal samples. Data analysis indicated that 16S rRNA gene copy numbers for Faecalibacterium prausnitzii, Enterococcus faecalis, Enterobacteriaceae, bifidobacteria, and lactic acid bacteria (Lactobacillus, Pediococcus, Leuconostoc, and Weissella) showed marked variation in the intestine of HBV cirrhotic patients. The Bifidobacteria/Enterobacteriaceae (B/E) ratio, which may indicate microbial colonization resistance of the bowel, was decreased significantly in turn from 1.15 ± 0.11 in healthy controls, 0.99 ± 0.09 in asymptomatic carriers, and 0.76 ± 0.08 in patients with chronic hepatitis B to 0.64 ± 0.09 in patients with decompensated HBV cirrhosis (for all, P < 0.01). This suggests that B/E ratio is useful for following the level of intestinal microecological disorder in the course of liver disease progression. The data for virulence gene abundance suggested increased diversity of virulence factors during liver disease progression. Fecal secretory IgA and tumor necrosis factor-α in decompensated HBV cirrhotic patients were present at higher levels than in other groups, which indicates that a complicated autoregulatory system tries to achieve a new intestinal microecological balance.
This paper references
10.1136/gut.13.9.682
Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease
T. Miettinen (1972)
10.1007/S00394-004-1205-4
PASSCLAIM1—Gut health and immunity
J. Cummings (2004)
10.1128/AEM.70.11.6459-6465.2004
Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children
Y. Song (2004)
10.1017/S0950268800050317
History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastrointestinal decontamination.
D. Waaij (1992)
High serum levels of secretory IgA in liver disease : possible liver origin of the circulating secretory component
DL Delacroix (1982)
10.1097/MPG.0b013e31816533d3
Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease
M. Joishy (2009)
10.1016/J.FEMSRE.2004.09.003
The interaction between bacteria and bile.
M. Begley (2005)
Rapid detection of enterotoxigenic Bacteroides fragilis in diarrhoeal faecal samples.
N. Sharma (2006)
10.1186/1471-2180-9-123
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
D. Mariat (2009)
10.1128/AEM.66.11.4605-4614.2000
Quantitative Analysis of Small-Subunit rRNA Genes in Mixed Microbial Populations via 5′-Nuclease Assays
M. Suzuki (2000)
10.1152/AJPCELL.00328.2003
Cell-specific expression of SERCA, the exogenous Ca2+ transport ATPase, in cardiac myocytes.
H. Ma (2004)
10.1002/bjs.6593
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
C. Lamb (2009)
10.1073/pnas.0804812105
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
H. Sokol (2008)
History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastrointestinal decontamination.
D. van der Waaij (1992)
10.1002/hep.21325
Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up
C. Castelnau (2006)
10.1099/00207713-44-4-812
The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.
M. Collins (1994)
10.1086/511794
Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.
F. Barbut (2007)
TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.
T. Ma (2004)
10.1016/S0140-6736(03)12489-0
Gut flora in health and disease
F. Guarner (2003)
10.1126/SCIENCE.1091334
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
A. Macpherson (2004)
10.1128/AEM.70.6.3575-3581.2004
Characterization of Bacterial Communities in Feces from Healthy Elderly Volunteers and Hospitalized Elderly Patients by Using Real-Time PCR and Effects of Antibiotic Treatment on the Fecal Microbiota
S. Bartosch (2004)
10.1038/bjc.1980.333
Faecal bile acids and clostridia in patients with breast cancer.
W. Murray (1980)
10.1111/J.1469-0691.2006.01494.X
A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer.
N. U. Toprak (2006)
10.1111/j.1872-034X.2007.00004.x
Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation
Pablo Palma (2007)
10.1016/j.cgh.2008.06.010
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
J. Jones (2008)
10.1016/S0016-5085(19)33805-3
Qualitative and quantitative relationships of the fecal flora in cirrhotic patients with portal systemic encephalopathy and following portacaval anastomosis.
M. Floch (1970)
10.4049/jimmunol.0901838
Secretory IgA-Mediated Neutralization of Shigella flexneri Prevents Intestinal Tissue Destruction by Down-Regulating Inflammatory Circuits1
S. Boullier (2009)
10.1111/j.1582-4934.2001.tb00164.x
Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases
Codruța-Romanița Usein (2001)
[Bacterial overgrowth in small intestine in patients with liver cirrhosis].
J. Chesta (1991)
10.1186/1742-4690-3-S1-S98
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
J. Brenchley (2006)
10.1128/IAI.68.7.3983-3989.2000
Prevalence of Virulence Genes and Clonality inEscherichia coli Strains That Cause Bacteremia in Cancer Patients
F. Hilali (2000)
The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity.
G. Martini (1957)
10.1073/pnas.0307317101
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut
K. Suzuki (2004)
10.11150/KANSENSHOGAKUZASSHI1970.74.134
[The prevalence of virulence-related genes, eaeA, aggR and astA, of localized and aggregative-adherent Escherichia coli (EPEC and EAggEC) in healthy children and age-matched patients with diarrhea].
K. Moriya (2000)
10.1111/j.1746-6342.2006.03217.x
Review article: bacterial flora and pathogenesis in hepatic encephalopathy
R. Williams (2007)
10.1046/j.0902-0063.2003.00097.x
Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation
S. Beckebaum (2003)
10.1086/426027
Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
S. Bartosch (2005)
10.1136/gut.23.6.475
Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver.
G. Pelletier (1982)
10.1152/AJPGI.00173.2003
TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation
T. Ma (2004)
10.2174/138161208784480234
Genomics can advance the potential for probiotic cultures to improve liver and overall health.
D. O'Sullivan (2008)
10.1016/J.VETMIC.2007.02.018
Prevalence of virulence genes in Escherichia coli strains recently isolated from young pigs with diarrhea in the US.
Weiping Zhang (2007)
[Effect of interferon alpha on liver fibrosis in patients with chronic hepatitis B].
H. Yu (2005)
10.1097/01.mpg.0000178437.87546.06
Fecal Tumor Necrosis Factor-α and Calprotectin as Differential Diagnostic Markers for Severe Diarrhea of Small Infants
N. Kapel (2005)
10.1007/s003840050236
Gut-liver axis
S. Zeuzem (2000)
Intestinal microecology and quality of life in irritable bowel syndrome patients
Jian-MinSi (2004)
10.1128/AEM.72.4.2359-2365.2006
Quantitative Real-Time PCR Analysis of Fecal Lactobacillus Species in Infants Receiving a Prebiotic Infant Formula
M. Haarman (2006)
10.1128/JCM.41.11.5134-5146.2003
Duplex Real-Time SYBR Green PCR Assays for Detection of 17 Species of Food- or Waterborne Pathogens in Stools
H. Fukushima (2003)
10.1007/BF01296753
High serum levels of secretory IgA in liver disease
D. Delacroix (2005)
10.1097/00001574-200411000-00011
Commensal bacteria in the gut: learning who our friends are
F. Yan (2004)
Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
S. Blum (2003)
10.1093/JN/138.6.1141
Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides.
P. Scholtens (2008)
10.3109/00365528509093766
Gut-liver interactions in the IgA system.
H. Hodgson (1985)
Intestinal endotoxemia as a pathogenetic mechanism in liver failure
De-WuHan (2002)
10.1046/j.1440-1746.2001.02444.x
Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis
A. Ramachandran (2001)



This paper is referenced by
10.1155/2018/2361963
The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection
Ruilin Yang (2018)
10.1016/J.ENG.2018.11.013
Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese Medicine
Yan-meng Lu (2019)
10.5772/intechopen.89340
Effect of Alcohol on Gut-Liver Axis and Adipose Tissue
Dhara Patel (2019)
10.3389/fphys.2012.00138
Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
L. Yang (2012)
10.1152/ajpgi.00118.2019
THE ROLE OF THE GUT MICROBIOTA IN LIVER DISEASE.
Somaya Albhaisi (2019)
10.1111/tid.12352
The relevance of intestinal dysbiosis in liver transplant candidates.
M. Grąt (2015)
10.1039/C8RA08049F
Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
Yanhuan Feng (2018)
10.1007/s13277-015-4423-x
Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma
N. Li (2015)
10.1016/j.hbpd.2020.01.003
Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
Benchen Rao (2020)
10.4172/2329-8901.1000154
Liver Diseases: The Role of Gut Microbiota and Probiotics
Jagtap Nitin (2016)
10.3390/jcm8020173
Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level
Yeojun Yun (2019)
10.1007/s00436-014-4074-7
Effect of diclazuril on intestinal morphology and SIgA expression in chicken infected with Eimeria tenella
Er-jie Tian (2014)
10.1007/978-4-431-55790-6_2
Microbiota and Liver
Kazumichi Abe (2016)
10.3382/ps/pey596
Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
Humera Hamid (2019)
10.1007/978-981-15-2385-4_4
Gut Microbiota and Liver Injury (II): Chronic Liver Injury.
Susan S Baker (2020)
10.1152/ajpgi.00161.2019
A Story of Liver and Gut Microbes: How Does the Intestinal Flora Affect Liver Disease? A Review of the Literature.
Mauro Giuffrè (2020)
An analysis of microbiota-targeted therapies in
Haifeng Lu (2014)
10.1007/978-3-319-23018-4_19
The Gut Microbiome and Cirrhosis: Clinical Aspects
Jasmohan S Bajaj (2016)
10.3389/fmicb.2019.01458
Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma
J. Ni (2019)
Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.
R. Lin (2015)
Gut microbes in the prevention and onset of metabolic disorders
Anniina Keskitalo (2019)
10.3390/microorganisms3040759
Gut Microbiota and Host Reaction in Liver Diseases
H. Fukui (2015)
10.1002/14651858.CD008716.pub3
Probiotics for people with hepatic encephalopathy.
R. Dalal (2017)
10.1101/782417
Sub-species niche specialization in the oral microbiome is associated with nasopharyngeal carcinoma risk in an endemic area of southern China
Justine W. Debelius (2019)
10.1016/j.jfma.2019.01.002
Microbiota and gastrointestinal cancer.
Meng-Tzu Weng (2019)
10.1186/s12887-015-0384-x
Obesity in school-aged children and its correlation with Gut E.coli and Bifidobacteria: a case–control study
Xiaolin Gao (2015)
10.1002/lt.24623
The evolving role of the microbiome in liver failure and liver transplantation.
K D Watt (2016)
10.3390/nu11030547
Human Gut Microbiome Response Induced by Fermented Dairy Product Intake in Healthy Volunteers
O. Volokh (2019)
10.1016/j.hbpd.2019.12.008
Fecal microbiota transplantation has therapeutic effects on chronic hepatits B patients via altering composition of gut microbiota.
Jiamin Lou (2020)
10.1007/s00248-011-9945-1
Assessment of the Fecal Lactobacilli Population in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis and Hepatitis B Cirrhosis Treated with Liver Transplant
Z. Wu (2011)
10.1155/2015/464969
Urinary Metabolite Profiling Offers Potential for Differentiation of Liver-Kidney Yin Deficiency and Dampness-Heat Internal Smoldering Syndromes in Posthepatitis B Cirrhosis Patients
X. Wang (2015)
10.1016/j.jcmgh.2015.04.003
The Gut Microbiota and Liver Disease
C. Llorente (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar